Orphan drugs inherently face a number of challenges in their development and value assessment. In this blog post, we describe the Mechanism of Coordinated Action (MoCA) initiative, and discuss why it can be beneficial to all parties involved and how it can improve decision making for – and access to – orphan drugs in European countries.
The Office of Health Economics is looking for a Project Manager with a proven track record of planning, managing and delivering multiple client facing projects simultaneously, helping the organisation to deliver on its objectives.
A new OHE Briefing by Martin Chalkley (University of York) and Jon Sussex (RAND Europe) provides a view of the NHS ownership debate through the lens of economics.
